Marijuana-Abusing Attention Deficit Hyperactivity Disorder (ADHD) Teens: Atomoxetine Treatment.

Trial Profile

Marijuana-Abusing Attention Deficit Hyperactivity Disorder (ADHD) Teens: Atomoxetine Treatment.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Apr 2016

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Acronyms DPMCDA
  • Most Recent Events

    • 14 Dec 2011 Additional trial acronym (DPMCD) identified as reported by ClinicalTrials.gov.
    • 27 Oct 2008 Actual patient number (2) added as reported by ClinicalTrials.gov.
    • 27 Oct 2008 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top